首页> 美国卫生研究院文献>Clinical and Diagnostic Laboratory Immunology >Stable Integration Vector for Nutrient Broth-Based Selection of Attenuated Listeria monocytogenes Strains with Recombinant Antigen Expression
【2h】

Stable Integration Vector for Nutrient Broth-Based Selection of Attenuated Listeria monocytogenes Strains with Recombinant Antigen Expression

机译:稳定的整合载体用于基于肉汤的重组抗原表达减毒李斯特菌菌株的选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recombinant Listeria monocytogenes strains induce strong cellular immune responses and may prove useful for antigen delivery for the vaccination of humans. However, the genetic systems currently available for the stable expression of recombinant antigens by L. monocytogenes rely on the use of antibiotic resistance genes. We report on a derivative, pPL2dalGlnA, of the Listeria monocytogenes pPL2 integration vector that completely lacks drug resistance genes. The selectable markers in pPL2dalGlnA are glutamine synthetase (GlnA) and alanine racemase (Dal). This novel vector was stably maintained in auxotropic L. monocytogenes strains that normally require d-alanine. The pPL2dalGlnA vector also partially restored the ability of an L. monocytogenes Δdal Δdat strain to colonize the spleens and livers of infected mice. A novel, highly attenuated strain of L. monocytogenes with quadruple deletions was also engineered by deleting the L. monocytogenes actA and plcB virulence genes from a Δdal Δdat strain. Infection of mice with recombinants of this mutant strain that express the antigen from pPL2dalGlnA were shown to elicit CD8+ T-cell responses to human immunodeficiency virus Tat. This vector system is thus useful for stable antigen expression and vaccination studies.
机译:重组单核细胞增生性李斯特菌菌株可诱导强烈的细胞免疫反应,并可能被证明可用于抗原接种以用于人类疫苗接种。但是,目前可用于单核细胞增生李斯特氏菌稳定表达重组抗原的遗传系统依赖于抗生素抗性基因的使用。我们报告了完全缺乏药物抗性基因的单核细胞增生李斯特菌pPL2整合载体的衍生物pPL2dalGlnA。 pPL2dalGlnA中的选择标记是谷氨酰胺合成酶(GlnA)和丙氨酸消旋酶(Dal)。该新型载体稳定地维持在通常需要d-丙氨酸的营养缺陷型单核细胞增生李斯特菌中。 pPL2dalGlnA载体还部分恢复了单核细胞增生李斯特氏菌ΔdalΔdat株在被感染小鼠的脾脏和肝脏中定殖的能力。还通过从ΔdalΔdat菌株中删除单核细胞增生李斯特菌actA和plcB毒力基因,设计了具有四重缺失的新型,高度减毒的单核细胞增生李斯特菌菌株。结果表明,用表达pPL2dalGlnA抗原的该突变株的重组体感染小鼠可引起对人免疫缺陷病毒Tat的CD8 + T细胞应答。因此,该载体系统可用于稳定的抗原表达和疫苗接种研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号